© 2020 – 2024 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
Image default
Tech

Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation.  Optellum, an Oxford-based medtech company that provides breakthrough AI technologies to help with early diagnosis of lung cancer, has attained CE marking for its Virtual Nodule Clinic – an AI-powered clinical […]

The post Optellum attains CE marking for its early lung cancer diagnosis AI technology appeared first on .

Related posts

Silobreaker introduces innovative Risk Scoring features to help threat intel teams assess and prioritise threats faster

AEA3

Smyth, Stapleton & Co selects Zylpha for document bundling

AEA3

Online Payment Security in Tech Platforms

AEA3